Author:
Merwat Shehzad N.,Kabbani Wareef,Adler Douglas G.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference17 articles.
1. McLeod DG (1997) Tolerability of nonsteroidal antiandrogens in the treatment of advanced prostate cancer. Oncologist 2(1):18–27
2. Janknegt RA, Abbou CC, Bartoletti R, Bernstein-Hahl L, Bracken B, Brisset JM et al (1993) Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol 149:77–83
3. Decensi AU, Boccardo F, Guarneri D, Positano N, Paoletti MC, Costantini M et al (1991) Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol 146(2):377–381
4. Boccardo F, Decensi AU, Guarner D, Martorana G, Fioretto L, Mini E et al (1991) Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. Cancer Detect Prev 15(6):501–503
5. Migliari R, Scarpa RM, Campus G, De Lisa A, Zucca I, D’Atri M et al (1991) Evaluation of efficacy and tolerability of Nilutamide and Buserelin in the treatment of advanced prostate cancer. Arch Ital Urol Nefrol Androl 63(1):147–153
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献